Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation - Summary - MDSpire

Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation

  • By

  • Lin Ran

  • Zhaoan Lian

  • Yong Tian

  • Li Qin

  • Yingchun Xiang

  • Xiaohao Yan

  • Chengyu Shui

  • June 16, 2026

  • 0 min

Share

Objective:

To investigate whether an integrated immune-inflammatory phenotype combining stromal tumor-infiltrating lymphocytes (TILs) and the systemic immune-inflammation index (SII) could improve recurrence-free survival (RFS) stratification after surgery in cervical cancer patients, thereby enhancing prognostic accuracy beyond conventional factors.

Approach:
    Key Findings:
    • 119 patients experienced an RFS event during follow-up, highlighting the clinical relevance of the findings.
    • Significant RFS differences were observed according to TIL category, SII category, and integrated phenotype, suggesting potential for tailored treatment strategies.
    • FIGO IIIC disease, positive margin status, and poor integrated phenotype were independently associated with worse RFS, indicating critical factors for risk assessment.
    • LASSO-Cox achieved the highest C-index (0.782) and best discrimination at 24 and 36 months, supporting its use in clinical decision-making.
    • Immunohistochemical validation indicated that the favorable phenotype was characterized by higher CD8+ cell density and lower CD163+ cell density, reinforcing the importance of immune profiling.
    Interpretation:

    An integrated immune-inflammatory phenotype combining stromal TILs and SII was independently associated with postoperative recurrence risk in cervical cancer and corresponded to distinct tissue immune states.

    Limitations:
    • The study is retrospective and may be subject to selection bias, and potential confounding factors were not fully accounted for.
    • Findings may not be generalizable to all cervical cancer populations due to the specific cohort studied.
    Conclusion:

    The integrated immune-inflammatory phenotype may provide a practical framework for recurrence risk stratification, while LASSO-Cox and RSF offer complementary prognostic perspectives, potentially guiding personalized treatment approaches.

Original Source(s)

Related Content